Affiliation:
1. Department of Neurology and Center of Clinical Neuroscience, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
2. Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
3. James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA
Abstract
Abstract
Objective
The role of inflammation and neuroimmune mechanisms, which have been documented in various neuropsychiatric disorders including the seizure subtype of functional neurological disorder, remains unclear in functional movement disorders (FMD). To explore these mechanisms, we analyzed selected inflammatory markers in cerebrospinal fluid (CSF) in patients with FMD.
Methods
We compared CSF markers in 26 patients with clinically established FMD (20 females; mean (SD) age 43.3 (10.9); disease duration 3.9 (3); range 0.1-11 years; mean follow-up after lumbar puncture 4.3 (2) years, range 0.5-7 years) and 26 sex and age-matched clinical controls with non-inflammatory non-neurodegenerative neurological disorders, mostly sleep disorders.
Results
65% of FMD patients vs. 15% of controls showed cytological abnormalities (i.e., increased white blood cells (WBC) count, signs of WBC activation, or both (odds ratio (OR) = 9.85, 95% confidence interval [2.37, 52.00], p < 0.01, corrected), with a significantly higher frequency of an isolated lymphocytic activation 35% vs. 0% (OR = ∞, 95% confidence interval [2.53, ∞], p < 0.05, corrected). There were no differences in CSF protein and albumin levels, quotient albumin, IgG index, and oligoclonal bands. CSF abnormalities were not associated with more severe motor symptoms or a higher frequency of depression in FMD.
Conclusions
Our results suggest a possible involvement of immune mechanisms in the pathophysiology of (at least a subtype of) FMD that deserves further investigation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference56 articles.
1. Diagnosis and management of functional neurological disorder;BMJ,2022
2. A framework for understanding the pathophysiology of functional neurological disorder;CNS Spectr,2020
3. The complex syndrome of functional neurological disorder;Psychol Med,2023
4. A Bayesian account of ‘hysteria’;Brain,2012
5. Symptoms and the body: taking the inferential leap;Neurosci Biobehav Rev,2017